Global Chemical CDMO Supply, Demand and Key Producers, 2023-2029

Global Chemical CDMO Supply, Demand and Key Producers, 2023-2029

The global Chemical CDMO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

CDMO, Contract development and manufacturing organization, is an emerging R&D and production outsourcing organization, mainly for the products of medical production enterprises and biotechnology companies, especially the process R&D and preparation of innovative products, process optimization, registration and verification batch production and commercial A service organization for customized R&D and production.

This report studies the global Chemical CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Chemical CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Chemical CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Chemical CDMO total market, 2018-2029, (USD Million)

Global Chemical CDMO total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Chemical CDMO total market, key domestic companies and share, (USD Million)

Global Chemical CDMO revenue by player and market share 2018-2023, (USD Million)

Global Chemical CDMO total market by Type, CAGR, 2018-2029, (USD Million)

Global Chemical CDMO total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Chemical CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, GenScript Biotech, Biosynth, Otsuka Chemical, AGC Pharma Chemicals, Jubilant Bhartia Group, Sinopep Allsino Bio Pharmaceutical and Wuxi Biologics (Cayman), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Chemical CDMO market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Chemical CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Chemical CDMO Market, Segmentation by Type
Small Molecule Preparations
Macromolecule Preparations

Global Chemical CDMO Market, Segmentation by Application
Pharmaceutical Company
Biotechnology Company
Others

Companies Profiled:
Lonza
Catalent
GenScript Biotech
Biosynth
Otsuka Chemical
AGC Pharma Chemicals
Jubilant Bhartia Group
Sinopep Allsino Bio Pharmaceutical
Wuxi Biologics (Cayman)
Porton Fine Chemicals
Zhejiang Jiuzhou Pharmaceutical
NYCRIST
Guangzhou Bositao Controlled Release Pharmaceutical
Charles River
Cambrex
Almac Group
Jubilant Pharmova
Cambrex
Siegfried Holding AG
Aenova Group
Samsung BioLogics

Key Questions Answered

1. How big is the global Chemical CDMO market?

2. What is the demand of the global Chemical CDMO market?

3. What is the year over year growth of the global Chemical CDMO market?

4. What is the total value of the global Chemical CDMO market?

5. Who are the major players in the global Chemical CDMO market?

6. What are the growth factors driving the market demand?